Lung Neoplasms  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00923949: Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

Terminated
2
1
US
Pioglitazone
National Cancer Institute (NCI)
Non-Small-Cell Lung Cancer
03/10
03/10
NCT01342770: Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

Terminated
2
6
US
Laboratory Biomarker Analysis, Pioglitazone Hydrochloride, Actos, Pioglitazone.HCl, Quality-of-Life Assessment, Quality of Life Assessment
National Cancer Institute (NCI)
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma, Stage IIB Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer
12/12
02/13
NCT00780234: Pioglitazone for Lung Cancer Chemoprevention

Completed
2
92
US
fluorescence bronchoscopy, quantitative high resolution CT scan, PIOGLITAZONE VS. PLACEBO 30 mg
VA Office of Research and Development
Lung Cancer, Endobronchial Dysplasia
06/16
08/17

Download Options